Monitoring unbound warfarin in drug combination therapy by pharmacokinetics and fluorospectrometry
-
Add time:07/18/2019 Source:sciencedirect.com
ObjectiveMonitoring the unbound drug concentration in blood in combination therapy is necessary, because its concentration determines the efficacy of drug therapy. This study was designed to explore the effect of Dan Hong Injection (DHI) on the unbound warfarin using two approaches including an in vivo pharmacokinetic and in vitro fluorescence studies.
We also recommend Trading Suppliers and Manufacturers of (R)-7-Hydroxy Warfarin (cas 63740-76-1). Pls Click Website Link as below: cas 63740-76-1 suppliers
Prev:Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study
Next:Warfarin Use Is Associated With Progressive Coronary Arterial Calcification) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS)07/20/2019
- Personalisation of warfarin therapy using thermal ink-jet printing07/21/2019
- Warfarin Use Is Associated With Progressive Coronary Arterial Calcification07/19/2019
- Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study07/17/2019
- Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: Implications for patients undergoing surgery07/16/2019
- Warfarin-exposed zebrafish embryos resembles human warfarin embryopathy in a dose and developmental-time dependent manner – From molecular mechanisms to environmental concerns07/15/2019
- Maintenance dose of warfarin beyond time in therapeutic range for preventing vascular events07/14/2019
- The Effect of Compound Danshen Dripping Pills on the Dose and Concentration of Warfarin in Patients with Various Genetic Polymorphisms07/13/2019
- Additive manufacturing of personalized orodispersible warfarin films07/12/2019
